Theragen Etex Co.,Ltd. (KOSDAQ:066700)
South Korea · Delayed Price · Currency is KRW 2,185.00
-130.00 (-5.62%)
At close: Jun 19, 2026
Theragen Etex Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 9,730 | 10,600 | -40,985 | 26,211 | 9,561 | -11,854 |
Depreciation & Amortization | 6,515 | 6,476 | 6,096 | 5,844 | 5,092 | 5,041 |
Loss (Gain) From Sale of Assets | -0.88 | -13.48 | -5,845 | -22,445 | -4,231 | 219.2 |
Asset Writedown & Restructuring Costs | - | - | 26.22 | 62.69 | 800.7 | 1,477 |
Loss (Gain) From Sale of Investments | - | -2.67 | -17.38 | -29.65 | -4.22 | - |
Loss (Gain) on Equity Investments | 945.67 | 796.92 | - | 357.07 | 65.07 | -12.93 |
Stock-Based Compensation | 738.99 | 583.16 | 161.9 | 659.55 | - | -0.75 |
Provision & Write-off of Bad Debts | 478.98 | 444.65 | 184.24 | 1,776 | -1,465 | 7,441 |
Other Operating Activities | -6,577 | -5,087 | 53,748 | 4,685 | 3,480 | 377.47 |
Change in Accounts Receivable | -5,394 | -3,102 | -1,181 | -8,712 | -3,202 | -7,168 |
Change in Inventory | 2,590 | 4,089 | -13,208 | -1,815 | -4,256 | 2,021 |
Change in Accounts Payable | 730.49 | -2,318 | 2,354 | 2,448 | 3,773 | 1,443 |
Change in Other Net Operating Assets | 977.77 | -1,497 | 454.79 | 3,083 | -19.87 | 5,022 |
Operating Cash Flow | 10,735 | 10,972 | 1,788 | 12,125 | 9,593 | 4,007 |
Operating Cash Flow Growth | 494.97% | 513.63% | -85.25% | 26.39% | 139.43% | -69.71% |
Capital Expenditures | -2,718 | -2,576 | -11,392 | -4,797 | -4,193 | -2,749 |
Sale of Property, Plant & Equipment | 16.01 | 20.37 | 727.26 | 9 | - | 24.64 |
Cash Acquisitions | - | - | -1,091 | -195.58 | - | - |
Divestitures | - | - | 6,980 | 30 | - | - |
Sale (Purchase) of Intangibles | -1,880 | -1,620 | -2,805 | -818.91 | -2,337 | -1,090 |
Investment in Securities | 702.89 | 920.11 | -6,303 | -9,526 | -2,166 | -129.51 |
Other Investing Activities | 492.87 | 735.5 | -105.76 | 185.47 | 8,804 | 257.42 |
Investing Cash Flow | -3,612 | -2,413 | -14,016 | -13,779 | 1,875 | -2,924 |
Long-Term Debt Issued | - | 6,897 | 40,696 | 37,471 | 1,000 | 5,367 |
Long-Term Debt Repaid | - | -15,191 | -28,038 | -32,379 | -7,612 | -8,857 |
Net Debt Issued (Repaid) | -7,899 | -8,294 | 12,658 | 5,091 | -6,612 | -3,490 |
Issuance of Common Stock | - | 12,997 | - | - | - | 387.79 |
Repurchase of Common Stock | -325.36 | - | - | - | - | - |
Dividends Paid | -99.14 | -99.14 | -99.14 | - | - | - |
Other Financing Activities | - | - | -0 | - | 1,336 | - |
Financing Cash Flow | -8,323 | 4,604 | 12,559 | 5,091 | -5,276 | -3,103 |
Foreign Exchange Rate Adjustments | 189.78 | -13.46 | 142.24 | -25.59 | -76.94 | -89.74 |
Miscellaneous Cash Flow Adjustments | - | - | - | - | - | -0 |
Net Cash Flow | -1,010 | 13,149 | 473.15 | 3,412 | 6,116 | -2,109 |
Free Cash Flow | 8,017 | 8,396 | -9,604 | 7,328 | 5,401 | 1,257 |
Free Cash Flow Growth | - | - | - | 35.69% | 329.54% | -87.69% |
Free Cash Flow Margin | 2.94% | 3.09% | -3.85% | 3.38% | 2.83% | 0.76% |
Free Cash Flow Per Share | 212.57 | 228.28 | -300.17 | 228.96 | 168.74 | 39.30 |
Cash Interest Paid | 1,797 | 1,959 | 2,326 | 1,604 | 1,222 | 1,009 |
Cash Income Tax Paid | 3,444 | 3,991 | 4,428 | 2,216 | 1,599 | 794.65 |
Levered Free Cash Flow | 6,658 | 6,391 | -12,795 | 3,651 | 2,886 | 6,272 |
Unlevered Free Cash Flow | 8,073 | 7,849 | -11,122 | 5,162 | 3,725 | 7,329 |
Change in Working Capital | -1,095 | -2,827 | -11,581 | -4,996 | -3,705 | 1,318 |